Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Pathological or cytological diagnosis of lung cancer (newly diagnosed or previously diagnosed); (2) Age =18 years old, gender unlimited; (3) Voluntarily join the clinical trial and sign the informed consent;(4) Receive anti-tumor or surgical treatment.
Exclusion criteria
Exclusion criteria: (1) patients with mental illness and lack of autonomous ability; (2) subjects that the investigator considers unable to cooperate with the completion of the clinical investigation; (3) According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in the working environment and unstable living environment, which are easy to cause the loss of follow-up; (4) Combined with active pulmonary tuberculosis, bronchial asthma, bronchiectasis, pulmonary abscess, pneumoconiosis and other respiratory diseases; (5) Patients who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival;Recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival;Solid tumor change;Tumor marker;European Cancer Research and Treatment Tissue Quality of Life Scale;Karnofsky Function status score; | — |
Countries
China
Contacts
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine